CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,472 | -14.9% | 22,071 | +13.4% | 0.00% | – |
| Q2 2023 | $33,468 | +69.6% | 19,458 | +48.9% | 0.00% | – |
| Q1 2023 | $19,728 | -8.4% | 13,065 | -2.9% | 0.00% | – |
| Q4 2022 | $21,538 | -65.8% | 13,461 | -43.0% | 0.00% | – |
| Q1 2022 | $63,000 | -36.4% | 23,628 | +3.2% | 0.00% | – |
| Q4 2021 | $99,000 | -35.7% | 22,899 | -24.1% | 0.00% | – |
| Q3 2021 | $154,000 | -4.3% | 30,175 | +19.2% | 0.00% | – |
| Q2 2021 | $161,000 | +64.3% | 25,325 | +99.9% | 0.00% | – |
| Q1 2021 | $98,000 | -44.6% | 12,668 | -53.1% | 0.00% | – |
| Q4 2020 | $177,000 | +23.8% | 27,034 | +25.8% | 0.00% | – |
| Q3 2020 | $143,000 | -21.9% | 21,482 | -2.2% | 0.00% | – |
| Q2 2020 | $183,000 | -1.6% | 21,976 | -9.5% | 0.00% | – |
| Q1 2020 | $186,000 | -68.8% | 24,293 | -54.4% | 0.00% | – |
| Q2 2019 | $597,000 | -7.4% | 53,241 | -11.2% | 0.00% | – |
| Q1 2019 | $645,000 | -41.0% | 59,954 | -17.3% | 0.00% | – |
| Q4 2018 | $1,094,000 | -32.9% | 72,474 | -17.8% | 0.00% | -100.0% |
| Q3 2018 | $1,631,000 | -84.5% | 88,151 | -80.8% | 0.00% | -66.7% |
| Q2 2018 | $10,500,000 | -22.2% | 459,297 | -3.2% | 0.00% | -40.0% |
| Q1 2018 | $13,499,000 | +24.7% | 474,498 | -7.5% | 0.01% | +25.0% |
| Q4 2017 | $10,829,000 | +345.1% | 512,994 | +283.1% | 0.00% | +300.0% |
| Q3 2017 | $2,433,000 | +29.0% | 133,916 | +10.1% | 0.00% | 0.0% |
| Q2 2017 | $1,886,000 | +253.2% | 121,683 | +293.5% | 0.00% | – |
| Q1 2017 | $534,000 | – | 30,925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 476,110 | $3,956,000 | 2.65% |
| MPM BioImpact LLC | 855,437 | $7,109,000 | 2.52% |
| Exane Asset Management | 87,876 | $730,250,000 | 0.90% |
| Congress Park Capital LLC | 94,661 | $787,000 | 0.58% |
| Perceptive Advisors | 3,253,923 | $27,040,000 | 0.54% |
| BVF INC/IL | 766,148 | $6,367,000 | 0.48% |
| RTW INVESTMENTS, LP | 1,039,593 | $8,639,000 | 0.33% |
| EcoR1 Capital, LLC | 410,000 | $3,407,000 | 0.31% |
| DAFNA Capital Management LLC | 100,000 | $831,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 79,193 | $658,000 | 0.27% |